{"id":"W2160134481","doi":"10.1016/s2213-2600(14)70201-2","title":"Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","year":2014,"lang":"en","type":"article","venue":"The Lancet Respiratory Medicine","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":484,"is_retracted":false,"has_abstract":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"MedImmune; European Respiratory Society","keywords":"Benralizumab; Medicine; Mepolizumab; Asthma; Placebo; Internal medicine; Population; Exacerbation; Eosinophilic; Dose-ranging study; Sputum; Immunology; Eosinophil; Gastroenterology; Tuberculosis; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003605711,0.0006553991,0.002147288,0.0003295682,0.0005500721,0.00005206578,0.00062222,0.0001767502,0.0004152595],"category_scores_gemma":[0.001769175,0.0003876125,0.0003667941,0.000417864,0.0005314904,0.0001940696,0.00008526482,0.0005205353,0.00004433135],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001571991,"about_ca_system_score_gemma":0.0002886559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003796571,"about_ca_topic_score_gemma":0.00004254888,"domain_scores_codex":[0.995212,0.00104348,0.001062873,0.0008578913,0.0008746352,0.0009491148],"domain_scores_gemma":[0.9958344,0.001345407,0.0004566572,0.001417311,0.0003285468,0.0006176404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6863488,0.005317357,0.01143221,0.0007069928,0.001869118,0.000303328,0.004806202,0.0001975069,0.1787319,0.0007546016,0.03304885,0.07648313],"study_design_scores_gemma":[0.7758304,0.03066363,0.01081457,0.0005535847,0.001320645,0.00002981371,0.00268286,0.003309319,0.00146821,0.00005692818,0.1725355,0.0007345304],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863874,0.001662124,0.0009105473,0.002724,0.001261448,0.0055288,0.00004996947,0.0003214622,0.001154216],"genre_scores_gemma":[0.9862993,0.0000254926,0.0001273704,0.003360774,0.00917525,0.0005537888,0.0001277665,0.0001170328,0.0002131651],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1772637,"threshold_uncertainty_score":0.9998576,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05700244567622967,"score_gpt":0.383372086142058,"score_spread":0.3263696404658284,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}